Business Description
Capha Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA13962W1086
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -195 | |||||
Debt-to-Equity | -0.99 | |||||
Debt-to-EBITDA | -7.04 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | -14.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -2800 | |||||
ROIC % | -15.27 | |||||
3-Year ROIIC % | -0.68 | |||||
ROC (Joel Greenblatt) % | -5500 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | N/A | |||||
EV-to-EBIT | -0.11 | |||||
EV-to-EBITDA | -0.11 | |||||
EV-to-FCF | -0.1 | |||||
Earnings Yield (Greenblatt) % | -909.09 | |||||
FCF Yield % | -90.8 |